Bacopa monnieri ： Attention & Focus Difficulties
C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。Research suggests Bacopa's modulation of dopamine and acetylcholine systems may support attention and focus. Effects require 8-12 weeks of consistent use for measurable improvement.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Dbacopa\u002Dmonnieri\u0026condition\u003Dattention\u002Dfocus';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
結論
Research suggests Bacopa's modulation of dopamine and acetylcholine systems may support attention and focus. Effects require 8-12 weeks of consistent use for measurable improvement.
Key Study Findings
Systematic Review
Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of …
Dose: None
vs: Placebo or methylphenidate
Outcome: ADHD symptom severity (inattention, hyperactivity)
効果: None
None
対象集団: ADHD patients (systematic review of supplements)
Systematic Review
n=1861
The effect of plant active substances on cognitive function in healthy older adults: a systematic …
Dose: None
vs: Placebo or no intervention
Outcome: Cognitive function (learning, memory, executive)
効果: Raisin SUCRA 95.1%; tart cherry 89.5% for memory
None
対象集団: Healthy older adults
Other
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma.
Dose: Bacopa monnieri (Brahmi)
vs: None
Outcome: Immunomodulatory effects in breast cancer
効果: None
None
対象集団: Retracted publication - invasive ductal carcinoma
Other
72 weeks
Online Promotion of "Brain Health" Supplements.
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
Review
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
Other
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
Key Statistics
8
研究数
600
参加者数
↑
Positive
C
グレード
Referenced Papers
Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
Systematic Review
Nutrients
2025
1 件の引用
The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of …
Systematic Review
Frontiers in pharmacology
2025
Medical oncology (Northwood, …
2024
2 件の引用
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Review
Journal of clinical …
2021
38 件の引用
The Senior care …
2021
2 件の引用
Alzheimer's research & …
2021
1 件の引用
Journal of ethnopharmacology
2017
98 件の引用
Medical hypotheses
2016
6 件の引用
Clinical drug investigation
2014
54 件の引用
Alternative medicine review …
1999
112 件の引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 300-600 mg/day standardized to 50% bacosides
- memorysupport:
- 300 mg/day for minimum 8-12 weeks
上限量： Not established; well-tolerated up to 600 mg/day in trials
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| None | -- | Positive | 1861 |
| Bacopa monnieri (Brahmi) | -- | Positive | -- |
| None | 72 weeks | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
推奨摂取タイミング： With meals; effects require 8-12 weeks of consistent use
Safety & Side Effects
報告されている副作用
- ⚠ Gastrointestinal discomfort (nausea, cramping, diarrhea)
- ⚠ Dry mouth
- ⚠ Fatigue in some individuals
- ⚠ Mild sedation at higher doses
既知の相互作用
- ● Thyroid medications (may increase thyroid hormone levels)
- ● Anticholinergic drugs (opposes cholinergic enhancement)
- ● Sedative medications (additive CNS depression)
- ● Calcium channel blockers (may enhance blood pressure lowering)
耐容上限摂取量： Not established; well-tolerated up to 600 mg/day in trials
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Bacopa monnieri help with Attention & Focus Difficulties?
Based on 8 studies with 600 participants, there is limited but promising evidence that Bacopa monnieri may support Attention & Focus Difficulties management. Our evidence grade is C (Some Evidence).
How much Bacopa monnieri should I take for Attention & Focus Difficulties?
Studies have used various dosages. A commonly studied range is 300-600 mg/day standardized to 50% bacosides. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bacopa monnieri?
Reported side effects may include Gastrointestinal discomfort (nausea, cramping, diarrhea), Dry mouth, Fatigue in some individuals, Mild sedation at higher doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bacopa monnieri and Attention & Focus Difficulties?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.
Related Evidence
に関する他の成分： Attention & Focus Difficulties
Bacopa monnieri 他の症状・状態について
References
- [1] Shatha Al Shahab et al.. Nutrients. 2025. Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review. doi:10.3390/nu17091482 PubMed
- [2] Xueyan Feng et al.. Front Pharmacol. 2025. The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of … doi:10.3389/fphar.2025.1672171 PubMed
- [3] Sohini Roy et al.. Med Oncol. 2024. Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma. doi:10.1007/s12032-024-02365-x PubMed
- [4] John E Lewis et al.. J Clin Transl Res. 2021. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. PubMed
- [5] Brittany R Block et al.. Sr Care Pharm. 2021. Online Promotion of "Brain Health" Supplements. doi:10.4140/TCP.n.2021.489 PubMed
- [6] Andrea Brioschi Guevara et al.. Alzheimers Res Ther. 2021. Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6. doi:10.1186/s13195-021-00844-1 PubMed
- [7] Michelle D Nemetchek et al.. J Ethnopharmacol. 2017. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. doi:10.1016/j.jep.2016.07.073 PubMed
- [8] Grace M McPhee et al.. Med Hypotheses. 2016. Cognitive training and Bacopa monnieri: Evidence for a combined intervention to alleviate age associated cognitive decline. doi:10.1016/j.mehy.2016.09.002 PubMed
- [9] Ananya Sadhu et al.. Clin Drug Investig. 2014. Management of cognitive determinants in senile dementia of Alzheimer's type: therapeutic potential of a novel polyherbal drug product. doi:10.1007/s40261-014-0235-9 PubMed
- [10] P M Kidd. Altern Med Rev. 1999. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。